WASHINGTON, D.C. — In a decisive move to combat the rising rates of maternal mortality in the United States, the Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN) has announced the receipt of a $500,000 grant from Merck for Mothers. This significant financial injection is earmarked for the development and nationwide implementation of the POST-BIRTH Triage Index (PBTI), a pioneering standardized tool designed to bridge the perilous gap in care that many women face after leaving the hospital following childbirth.
n
As the United States continues to grapple with maternal health outcomes that lag behind other developed nations, this initiative targets the specific "blind spot" of the American healthcare system: the emergency department. By providing clinicians in non-obstetric settings with a validated, evidence-based framework, AWHONN aims to ensure that life-threatening postpartum complications are identified and treated with the same urgency as a myocardial infarction or a stroke.
n
I. Main Facts: A Standardized Shield for New Mothers
n
The $500,000 grant represents a strategic investment in the "fourth trimester"—the 12-week period following childbirth—and beyond. While much of the traditional focus of maternal health has been on prenatal care and the delivery itself, data increasingly shows that the year following birth is when many mothers are most at risk.
n
The center-piece of this initiative is the POST-BIRTH Triage Index (PBTI). Unlike existing protocols that may be fragmented or localized, the PBTI is designed to be the first standardized postpartum triage tool specifically tailored for:
n
- n
- Traditional Hospital Emergency Departments (EDs)
- Urgent Care Centers
- Freestanding Emergency Departments
n
n
n
n
The necessity of this tool stems from a systemic disconnect. When a woman returns to a healthcare facility with a complication weeks after delivery, she often presents at an emergency room rather than a labor and delivery unit. In these settings, the medical staff—while highly skilled in general emergency medicine—may not immediately recognize symptoms like a severe headache or shortness of breath as signs of late-onset preeclampsia or postpartum cardiomyopathy. The PBTI seeks to provide these clinicians with a "red-flag" system to prioritize these patients immediately.
n
II. Chronology: From Warning Signs to Clinical Protocol
n
The development of the PBTI is not a standalone event but the evolution of a decade-long effort by AWHONN to improve maternal safety. To understand the trajectory of this new initiative, one must look at the foundation laid by the POST-BIRTH Warning Signs (PBWS) program.
n
The Foundation (2014–2024)
n
AWHONN’s PBWS program was originally designed as a patient-education tool. It empowered mothers to recognize symptoms such as heavy bleeding, chest pain, or obstructed breathing and instructed them on exactly when to seek emergency care. To date, this program reaches over 1.7 million postpartum patients annually through hospital discharge education and has been integrated into statewide maternal mortality prevention efforts across the country.
n
The Identification of the Gap (2024–2025)
n
Despite the success of educating patients, AWHONN identified a secondary failure point: what happens when the patient arrives at the hospital? Research conducted across 23 emergency departments in 17 states revealed a startling lack of specialized training. Clinicians in non-obstetric settings often lacked the standardized tools to categorize postpartum emergencies effectively. This research served as the catalyst for the PBTI.
n
The Roadmap (2026 and Beyond)
n
With the funding secured from Merck for Mothers, the implementation phase is set to begin in 2026. The timeline for the grant includes:
n
- n
- Establishment of a Multidisciplinary Expert Panel: Bringing together emergency physicians, obstetricians, nurses, and patient advocates to refine the index.
- Three Consecutive Research Studies: These studies will validate the tool’s effectiveness in real-world clinical settings, ensuring it reduces "time to treatment" for critical conditions.
- Protocol Expansion: Developing the educational resources necessary to train thousands of ED and urgent care clinicians nationwide.
n
n
n
n
III. Supporting Data: The High Stakes of Postpartum Care
n
The urgency of this grant is underscored by sobering statistics from the Centers for Disease Control and Prevention (CDC) and various Maternal Mortality Review Committees (MMRCs).
n
The Crisis of Preventability
n
According to national data, more than half of all pregnancy-related deaths in the United States occur between seven and 365 days postpartum. Perhaps the most tragic aspect of these figures is that the majority—upwards of 80% in some states—are considered preventable.
n
The primary killers during this period include:
n
- Cardiovascular Conditions: Including cardiomyopathy and heart failure.
- Hypertension: Late-onset preeclampsia and eclampsia.
- Hemorrhage: Delayed postpartum bleeding.
- Infection/Sepsis: Often presenting with vague symptoms that are easily overlooked in a busy ED.
The "Silo" Effect in Emergency Medicine
The research cited by AWHONN highlights a "silo" effect. In many hospital systems, the Emergency Department and the Labor & Delivery (L&D) department operate as entirely separate entities with different triage languages. A postpartum woman presenting with a high blood pressure reading in an ED might be placed in a standard queue, whereas in an L&D unit, that same reading would trigger an immediate "maternal code." The PBTI is designed to break down these silos, ensuring that the ED treats a postpartum patient with the specialized clinical pathway her condition requires.
IV. Official Responses: A Shared Vision for Maternal Safety
The partnership between AWHONN and Merck for Mothers represents a confluence of clinical expertise and corporate social responsibility aimed at a singular goal: saving lives.
Jonathan Webb, MBA, MPH, CEO of AWHONN, emphasized the transformative potential of the grant. "This investment represents a significant step forward in improving maternal safety during one of the most vulnerable periods in a woman’s healthcare journey," Webb stated. "By developing the first validated postpartum-specific triage index for emergency and urgent care settings, we can help clinicians identify life-threatening complications more quickly, improve care coordination and ultimately save lives."
Webb’s focus on "care coordination" is vital. The PBTI is not just a checklist; it is a communication tool that facilitates a smoother handoff between emergency physicians and obstetric specialists.
Jacquelyn Caglia, Head of Merck for Mothers, echoed this sentiment, highlighting the importance of timely intervention. "Merck for Mothers believes that every mother deserves access to high-quality, timely care throughout the postpartum period," said Caglia. "We are honored to support AWHONN’s efforts to expand this important work, building on the success of the Post-Birth Warning Signs program and helping to strengthen systems providing care for families across the United States during this critical time."
Merck for Mothers (known as MSD for Mothers outside the U.S. and Canada) has long been a global leader in maternal health, and this grant aligns with their broader mission to eliminate maternal mortality worldwide.
V. Implications: The Future of Maternal Health Systems
The introduction of the PBTI is expected to have far-reaching implications for the American healthcare landscape, touching on everything from clinical practice to health equity.
1. Standardization of Care
Currently, the quality of postpartum emergency care a woman receives can depend heavily on which hospital she visits. Some academic medical centers have robust protocols, while smaller community hospitals may not. The PBTI offers a "gold standard" that can be adopted by any facility, regardless of its size or resources, ensuring a baseline of safety for all mothers.
2. Addressing Racial Disparities
Maternal mortality in the U.S. disproportionately affects Black and Indigenous women, who are three to four times more likely to die from pregnancy-related causes than white women. These disparities are often exacerbated by "medical gaslighting" or the dismissal of symptoms in emergency settings. By implementing a standardized, data-driven triage index, the PBTI helps remove individual bias from the equation, ensuring that every woman’s symptoms are evaluated against an objective clinical framework.
3. Economic Impact
Preventable maternal complications are not only human tragedies but also significant economic burdens. Prolonged ICU stays, long-term disability from strokes, and the societal cost of maternal loss run into the billions of dollars. By catching complications early through the PBTI, the healthcare system can avoid the high costs of late-stage emergency interventions and long-term morbidity.
4. Empowerment of the Nursing Workforce
As the primary advocates for patients, nurses are at the forefront of this change. AWHONN’s role in this grant reinforces the importance of nursing leadership in healthcare innovation. The PBTI will provide nurses in EDs with the institutional backing to advocate for their postpartum patients, giving them a validated tool to "stop the line" and demand immediate obstetric consultation when necessary.
Conclusion
The $500,000 grant from Merck for Mothers to AWHONN is more than a financial transaction; it is a catalyst for a systemic shift in how the United States views and treats the postpartum period. By focusing on the critical intersection of emergency medicine and obstetrics, the POST-BIRTH Triage Index promises to close the gap that has claimed too many lives. As implementation begins in 2026, the healthcare community will be watching closely, hopeful that this initiative marks the beginning of the end for the American maternal mortality crisis.
About AWHONN
The Association of Women’s Health, Obstetric and Neonatal Nurses is a 501(c)3 nonprofit membership organization dedicated to empowering and supporting nurses who care for women and newborns. Their mission focuses on research, education, and advocacy to advance the health of families nationwide.
About Merck for Mothers
Merck for Mothers is a global initiative by Merck (known as MSD outside the U.S.) aimed at creating a world where no woman has to die while giving life. The program supports innovative solutions to improve maternal health outcomes globally.
